Variables | Findings (n = 30) |
---|---|
Age (years), median (IQR) | 35 (27–53) |
Gender, n (%) | |
 Male | 17(56.7%) |
 Female | 13(43.3%) |
ASA-PS class, n (%) | |
 I | 10 (33.3%) |
 II | 17 (56.7%) |
 III | 3 (10%) |
BMI (kg/m2), mean ± SD | 29.45 ± 5.56 |
Type of surgery, n (%) | |
 General | 13 (43.3%) |
 Urology | 4 (13.3%) |
 ENT | 10 (33.3%) |
 Plastic | 2 (6.7%) |
 OB/GYN | 1 (3.3%) |
NMBD used, n (%) | |
 Succinylcholine | 1 (3.3%) |
 Rocuronium | 26 (86.7%) |
 Cisatracurium | 3 (10%) |
Reversal used, n (%) | |
 None | 7 (23.3%) |
 Neostigmine | 23 (76.7%) |